While we did observe increased frequencies of Granzyme B+ (GzmB+) T cells in the IL-2–expanded group compared with those expanded with IL-7, we also noted an increased baseline frequency of GzmB+ T cells in the unstimulated/IL-2–expanded and tumor-only control groups (Figure 6O). The gene discussed is IL2; the disease is neoplasm.